Claims for Patent: 10,023,872

Summary for Patent: 10,023,872

Title:	Methods for producing heterologous polypeptides in mutants of trichoderma
Abstract:	The present invention relates to mutants of a parent Trichoderma strain, comprising a polynucleotide encoding a polypeptide and one or more genes selected from the group consisting of a peptaibol synthetase gene, a paracelsin synthetase gene, a first terpene cyclase gene, a second terpene cyclase gene, and a third terpene cyclase gene, wherein one or more of the genes are modified rendering the mutant strain deficient in the production of one or more of the enzymes selected from the group consisting of a peptaibol synthetase, a paracelsin synthetase, a first terpene cyclase, a second terpene cyclase, and a third terpene cyclase compared to the parent Trichoderma strain when cultivated under identical conditions. The present invention also relates to methods of producing a polypeptide in such mutants and methods for producing such mutants.
Inventor(s):	Merino; Sandra (Davis, CA), Quintos; Judilee (Davis, CA), Yaver; Debbie (Davis, CA)
Assignee:	Novozymes, Inc. (Davis, CA)
Application Number:	14/652,755
Patent Claims:	1. A method of producing a heterologous polypeptide, comprising: cultivating a mutant of a parent Trichoderma reesei strain in a medium for the production of the heterologous polypeptide, wherein the mutant strain comprises a polynucleotide encoding the heterologous polypeptide and a peptaibol synthetase gene and a paracelsin synthetase gene, wherein the peptaibol synthetase gene and the paracelsin synthetase gene are modified rendering the mutant strain deficient in the production of a peptaibol synthetase, and a paracelsin synthetase compared to the parent Trichoderma reesei strain when cultivated under identical conditions, wherein the heterologous polypeptide is selected from the group consisting of an acetylmannan esterase, acetylxylan esterase, aminopeptidase, alpha-amylase, arabinanase, arabinofuranosidase, carbohydrase, carboxypeptidase, catalase, cellobiohydrolase, cellulase, cellulose inducing protein, chitinase, coumaric acid esterase, cyclodextrin glycosyltransferase, cutinase, cyclodextrin glycosyltransferase, deoxyribonuclease, endoglucanase, esterase, expansin, feruloyl esterase, AA9 polypeptide, alpha-galactosidase, beta-galactosidase, glucocerebrosidase, glucose oxidase, alpha-glucosidase, beta-glucosidase, glucuronidase, glucuronoyl esterase, haloperoxidase, hemicellulase, invertase, isomerase, laccase, ligase, lipase, mannanase, mannosidase, mutanase, oxidase, pectinolytic enzyme, peroxidase, phospholipase, phytase, phenoloxidase, polyphenoloxidase, proteolytic enzyme, ribonuclease, swollenin, alpha-1,6-transglucosidase, transglutaminase, urokinase, xylanase, and beta-xylosidase. 2. The method of claim 1, further comprising recovering the heterologous polypeptide from the cultivation medium. 3. The method of claim 1, wherein the peptaibol synthetase gene encodes a polypeptide having peptaibol synthetase activity selected from the group consisting of: (a) a polypeptide comprising an amino acid sequence having at least 60% sequence identity to SEQ ID NO: 2; (b) a polypeptide encoded by a polynucleotide that hybridizes under at least low stringency conditions with SEQ ID NO: 1 or the cDNA sequence thereof; or the full-length complement thereof; (c) a polypeptide encoded by a polynucleotide comprising a nucleotide sequence having at least 60% sequence identity to SEQ ID NO: 1 or the cDNA sequence thereof; and (d) a polypeptide comprising or consisting of SEQ ID NO: 2. 4. The method of claim 1, wherein the paracelsin synthetase gene encodes a polypeptide having paracelsin synthetase activity selected from the group consisting of: (a) polypeptide comprising or consisting of an amino acid sequence having at least 60% sequence identity to SEQ ID NO: 4; (b) a polypeptide encoded by a polynucleotide that hybridizes under at least low stringency conditions with SEQ ID NO: 3 or the cDNA sequence thereof; or the full-length complement thereof; (c) a polypeptide encoded by a polynucleotide comprising or consisting of a nucleotide sequence having at least 60% sequence identity to SEQ ID NO: 3 or the cDNA sequence thereof; and (d) a polypeptide comprising or consisting of SEQ ID NO: 4.

Details for Patent 10,023,872

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Microbix Biosystems Inc.	KINLYTIC	urokinase	For Injection	021846	January 16, 1978		2033-12-20